Offer - Urjas Oil for just ₹ 1 X
Dapazee-M is an allopathic medicine The correct dosage of Dapazee-M depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Dapazee-M is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Dapazee-M safe for pregnant women?
Pregnant women may get mild side effects from Dapazee-M.
Is the use of Dapazee-M safe during breastfeeding?
Breastfeeding women may feel side effects of Dapazee-M. If you see any side effects, stop taking Dapazee-M immediately and talk to your doctor. Take Dapazee-M again, only after your doctor's advice.
What is the effect of Dapazee-M on the Kidneys?
Dapazee-M is completely safe for kidneys.
What is the effect of Dapazee-M on the Liver?
There are no any side effects of Dapazee-M on the liver.
What is the effect of Dapazee-M on the Heart?
Using Dapazee-M does not have any harmful effects on the heart.
Dapazee-M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dapazee-M unless your doctor advises you to do so -
Is this Dapazee-M habit forming or addictive?
Dapazee-M is not addictive in nature.
Interaction between Food and Dapazee-M
There is no information on the effects of taking Dapazee-M with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Dapazee-M
Taking Dapazee-M with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826